Products3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lanthanum carbonate
Product Details
Lanthanum carbonate
Product Details
Lanthanum carbonate
Product Details
Drug Labeling Information
Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.
RECENT MAJOR CHANGES SECTION
RECENT MAJOR CHANGES
Contraindications (4) 8/2024
INDICATIONS & USAGE SECTION
Highlight: * Lanthanum carbonate chewable tablets are a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). (1)
1 INDICATIONS AND USAGE
Lanthanum carbonate chewable tablets are a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD).
Management of elevated serum phosphorus levels in patients with ESRD usually includes all of the following: reduction in dietary intake of phosphate, removal of phosphate by dialysis, and reduction of intestinal phosphate absorption with phosphate binders.
DOSAGE FORMS & STRENGTHS SECTION
Highlight: * Lanthanum carbonate chewable tablets: 500 mg, 750 mg, and 1,000 mg. (3)
3 DOSAGE FORMS AND STRENGTHS
Lanthanum carbonate chewable tablets: 500 mg, 750 mg, and 1,000 mg.